However, our in vitro genome‐wide immune screen results showed that knockout of Atf4, Ddit3, Slc7a11, or Slc3a2 alone did not significantly enhance tumor cell sensitivity to T cell–mediated killing (Figure S11B, Supporting Information). Here, SLC3A2 is linked to neoplasm.